JSL OSTEOPATHY LTD
Executive Summary
JSL OSTEOPATHY LTD is an early-stage specialist medical practice with a focused osteopathy offering and a strengthened financial base after initial operational challenges. Its lean structure and niche expertise position it well for local market penetration, though scaling capacity and competitive pressures require strategic investments in service diversification, partnerships, and brand development. To capitalize on growth opportunities, the company must address resource constraints and regulatory complexities to build sustainable competitive advantages in a fragmented healthcare sector.
View Full Analysis Report →- Legal registered address
- 2 Cowley Crescent Uxbridge England UB8 2HE Copied!
Latest financial results as of 13 November 2025- Current assets
- £6.01k
- Current creditors
- £1.10k
- Shareholders funds
- £4.67k
View full financial accounts- Current assets
- £6.01k
- Current creditors
- £1.10k
- Shareholders funds
- £4.67k
- Company number
- 14339632 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2026
Confirmation statement
Latest confirmation statement statement dated 15 August 2025
Next statement due by 29 August 2026
Nature of business (SIC)
86220 - Specialists medical practice activities
Latest company documents
| Date | Description |
|---|---|
| 15/08/2515 August 2025 | Confirmation statement made on 2025-08-15 with no updates |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 27/08/2427 August 2024 | Confirmation statement made on 2024-08-24 with no updates |
| 29/04/2429 April 2024 | Micro company accounts made up to 2023-09-30 |
| 30/09/2330 September 2023 | Annual accounts for year ending 30 Sep 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company